Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001879785-21-000039
Filing Date
2021-12-14
Accepted
2021-12-14 17:17:13
Documents
1
Period of Report
2021-12-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3149
  Complete submission text file 0001879785-21-000039.txt   4634
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERECOR INC. 400 E. PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Sullivan Christopher Ryan (Reporting) CIK: 0001810417 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 211491942